FindTrial
Sign In

Ayurvedic Management of Rheumatoid Arthritis

An open labelled randomised controlled parallel group clinical study to evaluate the efficacy Of PRASARINI SANDHANAM in management of AMAVATA W.S.R TO RHEUMATOID ARTHRITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024674
Enrollment
30
Registered
2020-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor

Interventions

Intervention1: Simhanada Guggulu: Ingredients - Harithaki, Vibhitaki, Amalaki, Shuddha Gandhaka, Shuddha Guggulu, Eranda Taila ,Dosage - 2 TID mode of Administration - orally no of days -30 Control In

Sponsors

Dr Ramyashree Nagendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to give informed consent for research 2. Subjects who satisfy 4 criteria out of 7 of ARA 3. Subjects with classical signs and symptoms of Amavata

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from Rheumatoid arthritis secondary to any systemic diseases 2. Patients on any other medications like DMARD, NSAID, Corticosteroids 3. Patients having complications like swan neck deformity, ulnar deviation and any other diseases which interfere with the course of disease and treatment will be excluded

Design outcomes

Primary

MeasureTime frame
Improvement in General Functional CapacityTimepoint: On 45th day the assessment will be done—

Secondary

MeasureTime frame
To elicit the Quality of Life in patients with Amavata w.s.r to Rheumatoid ArthritisTimepoint: 15th, 30th, 45th day—

Countries

India

Contacts

Public ContactDr Gopala Krishna G

Sri Sri College of Ayurvedic Science and Research

getgopee@yahoo.com9448173128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026